AMPK(A2/B1/G1),active enzymes

点击图片查看原图
单价: 595.00
品牌: signalchem
销量: 累计出售 0
评价: 已有 0 条评价
人气: 已有 52 人关注
更新: 2021-05-16
数量: 减少 增加份 库存999份
立即购买   加入购物车
看了又看 更多>
 
 
货号: P48-10H-10
保存条件: –70
规格: 10ug
Description: Recombinant full-length human AMPK (combination of A2/B1/G1 subunits) was expressed by baculovirus in Sf9 insect cells using a C-terminal His tags.

 
     Species: Human

 
     Tag: HIS tags

 
     Expression System: Sf9 insect cells using baculovirus

 
     Sequence: Full Length

 
     Genbank Number: NM_006252  NM_006253  NM_002733

 
     
Specific Activity : Sample Kinase Activity Plot. For specific information on a given lot, see related technical data sheet. 



Purity : Sample Purity Data. For specific information on a given lot, see related technical data sheet. 



Storage, Stability and Shipping : Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles. 

Applications : Kinase Assay, Western Blot 

Molecular Weight : ~69kDa (A2), ~38kDa (B1), and ~40kDa (G1). 

Gene Aliases : Subunits A2: PRKAA2, AMPK, AMPK2, PRKAA Subunit B1: PRKAB1, AMPK, HAMPKb, MGC17785 Subunit G1: PRKAG1, AMPKG, MGC8666 

Scientific Background : AMPK (A2/B1/G1) plays a key role in insulin signaling pathway and is a major therapeutic target for the treatment of diabetes (1). AMPK is viewed as a fuel sensor for glucose and lipid metabolism by modulating the activity of the autonomous nervous system in vivo. Short-term overexpression of a constitutively active form of AMPK in the liver leads to mild hypoglycemia and fatty liver due to increased fatty acid utilization (2). 

References : 
1. Viollet, B. et al: Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 2003; 31; 216–219. 

2. Foretz, M. et al: Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes, 2005; 54 (5);1331-1339. 

Formulation : 50mM sodium phosphate, pH 7.0, 300mM NaCl, 150mM imidazole, 0.1mM PMSF, 0.25mM DTT, 25% glycerol. 
温馨提示:不可用于临床治疗。